WrightV.Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis. Ann Rheum Dis. Jun1961; 20: 123–132.
5.
ZeichnerJ.A.Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas. J Clin Aesthet Dermatol. Sep2010; 3(9): 37–40.
6.
LebwohlM., TingP.T., KooJ.Y.Psoriasis treatment: traditional therapy. Ann Rheum Dis. Mar2005; 64 Suppl 2: ii83–86.
7.
TownsleyW.The control of diseases of tissue reactivity by cortisone. Ulster Med J. Nov1951; 20(2): 159–171.
8.
KersleyG.D.Amethopterin (methotrexate) in connective tissue disease-psoriasis and polyarthritis. Ann Rheum Dis. Jan1968; 27(1): 64–66.
FredrikssonT.Antipsoriatic activity of retinoic acid (vitamin A acid). Dermatologica.1971; 142(3): 133–136.
11.
OttF., BollagW.[Treatment of psoriasis with an orally administered effective new vitamin A acid derivative. Preliminary report]. Schweiz Med Wochenschr. Apr 51975; 105(14): 439–441.
12.
EllisC.N., FradinM.S., MessanaJ.M.Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med. Jan 311991; 324(5): 277–284.
13.
MuellerW., HerrmannB.Cyclosporin A for psoriasis. N Engl J Med. Sep 61979; 301(10): 555.
14.
van WeeldenH., De La FailleH.B., YoungE., van der LeunJ.C.A new development in UVB phototherapy of psoriasis. Br J Dermatol. Jul1988; 119(1): 11–19.
15.
SmithE.L., PincusS.H., DonovanL., HolickM.F.A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxy vitamin D3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol. Sep1988; 19(3): 516–528.
16.
VakirlisE., KastanisA., IoannidesD.Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris. Ther Clin Risk Manag. Feb2008; 4(1): 141–148.
17.
OhC.J., DasK.M., GottliebA.B.Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions. J Am Acad Dermatol. May2000; 42(5 Pt 1): 829–830.
18.
KryczekI., BruceA.T., GudjonssonJ.E.Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol. Oct 12008; 181(7): 4733–4741.
19.
GordonK.B., StroberB.E.Understanding therapeutic pathways and comorbidities in psoriasis. Semin Cutan Med Surg. Mar2014; 33(2 Suppl 2): S20–23.
20.
RistowH.J.A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein. Proc Natl Acad Sci U S A. Apr1987; 84(7): 1940–1944.
21.
RitchlinC., Haas-SmithS.A., HicksD., CappuccioJ., OsterlandC.K., LooneyR.J.Patterns of cytokine production in psoriatic synovium. J Rheumatol. Aug1998; 25(8): 1544–1552.
22.
ZhangL.Y., OgdieA.R., SchumacherH.R.Light and electron microscopic features of synovium in patients with psoriatic arthritis. Ultrastruct Pathol. Aug2012; 36(4): 207–218.
HelmsC., CaoL., KruegerJ.G.A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet. Dec2003; 35(4): 349–356.
26.
SpeckmanR.A., Wright DawJ.A., HelmsC.Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum Genet. Jan2003; 112(1): 34–41.
27.
LiuY., HelmsC., LiaoW.A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. Mar2008; 4(3): e1000041.
28.
JordanC.T., CaoL., RobersonE.D.Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am J Hum Genet. May 42012; 90(5): 796–808.
29.
OnoufriadisA., SimpsonM.A., PinkA.E.Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. Sep 92011; 89(3): 432–437.
30.
GelfandJ.M., NeimannA.L., ShinD.B., WangX., MargolisD.J., TroxelA.B.Risk of myocardial infarction in patients with psoriasis. Jama. Oct 112006; 296(14): 1735–1741.
31.
NeimannA.L., ShinD.B., WangX., MargolisD.J., TroxelA.B., GelfandJ.M.Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. Nov2006; 55(5): 829–835.
32.
SettyA.R., CurhanG., ChoiH.K.Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med. Nov2007; 120(11): 953–959.
33.
SettyA.R., CurhanG., ChoiH.K.Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med. Aug 13–272007; 167(15): 1670–1675.
34.
MehtaN.N., AzfarR.S., ShinD.B., NeimannA.L., TroxelA.B., GelfandJ.M.Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. Apr2010; 31(8): 1000–1006.
